EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Characterization of RHD Variability and RhCE Phenotypes in a Hospital-Based Cohort from Beijing, China

Ziyao Yang, Aizhi Li, Wei Wang, Meng Wang, Yingqi Wang, Yaning Zhou, Peng Wang

Transfusion Medicine and Hemotherapy · 16.11.2026

DOI: 10.1159/tmh/aevag012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion Medicine and Hemotherapy, online erschienen am 16.11.2026. Verfasst von Ziyao Yang und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Rh blood group system is second only to the ABO system in clinical significance. RhD antigen's high immunogenicity can induce anti-D antibodies, causing hemolytic transfusion reactions and hemolytic disease of the fetus and newborn. Accurate RhD genotyping is essential for transfusion safety and prenatal care, particularly in Chinese populations with diverse genetic variants.

Objective

To investigate the RHD gene polymorphism in Beijing and enhance the understanding of RHD genetic diversity in East Asia.

Methods

A retrospective study was conducted on 134 individuals with serologically RhD-negative phenotypes at Peking University First Hospital in 2023. RHD genotyping was performed using Polymerase Chain Reaction-Sequence Specific Primer(PCR-SSP), and sequencing of exons 1–10 of the RHD gene was done for unclassified cases. RhCE phenotyping was also conducted. To further characterize the novel variant and exclude interference from homologous RHCE sequences, PacBio long-read sequencing was performed.

Results

Among the 134 individuals included in the study, 131 (97.76%) were successfully genotyped by PCR-SSP. The most common RHD genotype was RHD*01N.01 (59.70%), identified in 80 cases. Among individuals carrying RHD*01EL.01, zygosity analysis based on PCR-SSP identified RHD*01EL.01/RHD*01N.01 in 20 cases (14.93%) and RHD*01EL.01/RHD*01EL.01 in 7 cases (5.22%). Other relatively common genotypes included RHD*01N.03 (8.96%), RHD*01N.16 (2.99%) and RHD*weak partial 15 (2.99%). Two patients carried multiple RHD variants: one patient harbored both RHD*01N.25 and RHD*weak D type 25, while the other carried RHD*weak partial 15 and RHD*01EL.01. RhCE phenotyping revealed ccee as the most common phenotype (52.99%), particularly among individuals with RHD deletion. Three samples remained unresolved by PCR-SSP and underwent further RHD exon sequencing. Two rare alleles, RHD*weak D type 9 and RHD*weak partial 11, were identified. In addition, a novel variant combination, c.208C>T;c.210dupG, was detected. PacBio long-read sequencing confirmed that both variants were located within the RHD gene. The c.210dupG variant is predicted to cause a frameshift and premature termination, suggesting a null or extremely weak RHD allele.

Conclusions

The study identifies significant genetic diversity in the RHD gene among individuals with serologically RhD-negative phenotypes in Beijing, highlighting the importance of RHD genotyping for precision transfusion medicine and contributing to the global RHD genetic database.

Zitieren

APA

Yang, Z., Li, A., Wang, W., Wang, M., Wang, Y., Zhou, Y., & Wang, P. (2026). Molecular Characterization of RHD Variability and RhCE Phenotypes in a Hospital-Based Cohort from Beijing, China. Transfusion Medicine and Hemotherapy. https://doi.org/10.1159/tmh/aevag012

Vancouver

Yang Z, Li A, Wang W, Wang M, Wang Y, Zhou Y, et al. Molecular Characterization of RHD Variability and RhCE Phenotypes in a Hospital-Based Cohort from Beijing, China. Transfusion Medicine and Hemotherapy. 2026. doi:10.1159/tmh/aevag012

BibTeX
@article{Yang2026,
  author = {Yang, Ziyao and Li, Aizhi and Wang, Wei and Wang, Meng and Wang, Yingqi and Zhou, Yaning and Wang, Peng},
  title = {Molecular Characterization of RHD Variability and RhCE Phenotypes in a Hospital-Based Cohort from Beijing, China},
  journal = {Transfusion Medicine and Hemotherapy},
  year = {2026},
  doi = {10.1159/tmh/aevag012}
}
Kostenlos starten →